SCHEMBL6465638

SCHEMBL6465638

COCS(=O)(=O)c1nc(Nc2ccc(C(F)(F)F)nc2)c2ncc(-c3ncccc3C(F)(F)F)cc2n1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4972789 0.84 TRPV1 (0.81) TRPV1
SCHEMBL27600421 0.83 TRPV1 (0.61) TRPV1
SCHEMBL6449846 0.78 TRPV1 (0.69) TRPV1
SCHEMBL4971955 0.77 TRPV1 (0.78) TRPV1
SCHEMBL6471306 0.76 TRPV1 (0.68) TRPV1
SCHEMBL4919140 0.74 TRPV1 (1.00) TRPV1
SCHEMBL14283441 0.74 TRPV1 (0.79) TRPV1
SCHEMBL4972387 0.74 TRPV1 (0.83) TRPV1
SCHEMBL14283302 0.74 TRPV1 (0.84) TRPV1
SCHEMBL4975222 0.74 TRPV1 (0.84) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581225-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2005-10-05 EP disclosed
WO-2004054582-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2004-07-01 WO disclosed